This is in agreement with the previous findings of Kudo and coworkers who studied the potential of ADGRB1 as an anti-angiogenic factor in RCC based on the known inverse correlation of its expression with vascular density in other tumor types (Kudo et al., 2007). Here, ADGRB1 is linked to neoplasm.